Eisai Co., Ltd. (OTCMKTS:ESALY – Get Free Report) crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $61.51 and traded as low as $61.00. Eisai shares last traded at $61.51, with a volume of 331,800 shares changing hands.
Eisai Trading Down 2.1%
The firm has a market cap of $17.64 billion, a P/E ratio of 70.70, a price-to-earnings-growth ratio of 2.46 and a beta of 0.31. The company has a current ratio of 2.20, a quick ratio of 1.77 and a debt-to-equity ratio of 0.10. The company’s fifty day moving average price is $61.51 and its two-hundred day moving average price is $61.51.
About Eisai
Eisai Co, Ltd. is a research-driven global pharmaceutical company headquartered in Tokyo, Japan. Founded in 1941 by Toyoji Naito, Eisai focuses on the discovery, development, manufacture and commercialization of prescription medicines and related healthcare products. The company emphasizes neuroscience and oncology as core therapeutic areas and invests in both small-molecule and biologic research to address unmet medical needs.
Among its well-known products, Eisai developed and markets Aricept (donepezil), a widely used treatment for the symptoms of Alzheimer’s disease, and LENVIMA (lenvatinib), an oncology therapy for several tumor types.
See Also
- Five stocks we like better than Eisai
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for Eisai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eisai and related companies with MarketBeat.com's FREE daily email newsletter.
